Lite Strategy, Inc. (LITS)
1.03
+0.06
(+5.96%)
USD |
NASDAQ |
Nov 06, 10:07
Lite Strategy Price to Book Value : 0.8020 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.7569 |
| November 04, 2026 | 0.8409 |
| November 03, 2026 | 0.8097 |
| November 02, 2026 | 0.7534 |
| October 30, 2026 | 0.872 |
| October 29, 2026 | 0.9109 |
| October 28, 2026 | 0.9577 |
| October 27, 2026 | 0.8993 |
| October 26, 2026 | 0.872 |
| October 23, 2026 | 0.9032 |
| October 22, 2026 | 0.9265 |
| October 21, 2026 | 0.9654 |
| October 20, 2026 | 0.9265 |
| October 19, 2026 | 0.9032 |
| October 16, 2026 | 0.8954 |
| October 15, 2026 | 0.9304 |
| October 14, 2026 | 0.9109 |
| October 13, 2026 | 0.9421 |
| October 12, 2026 | 0.9499 |
| October 09, 2026 | 0.9888 |
| October 08, 2026 | 0.9499 |
| October 07, 2026 | 0.9888 |
| October 06, 2026 | 1.098 |
| October 05, 2026 | 1.09 |
| October 02, 2026 | 1.074 |
| Date | Value |
|---|---|
| October 01, 2026 | 1.071 |
| September 30, 2026 | 1.028 |
| September 29, 2026 | 1.071 |
| September 28, 2026 | 1.059 |
| September 25, 2026 | 1.121 |
| September 24, 2026 | 1.113 |
| September 23, 2026 | 0.9187 |
| September 22, 2026 | 1.012 |
| September 21, 2026 | 0.9966 |
| September 18, 2026 | 0.8798 |
| September 17, 2026 | 0.8097 |
| September 16, 2026 | 0.7942 |
| September 15, 2026 | 0.8487 |
| September 14, 2026 | 0.8954 |
| September 11, 2026 | 0.8642 |
| September 10, 2026 | 0.8253 |
| September 09, 2026 | 0.8253 |
| September 08, 2026 | 0.8564 |
| September 04, 2026 | 0.8876 |
| September 03, 2026 | 0.8097 |
| September 02, 2026 | 0.8097 |
| September 01, 2026 | 0.7739 |
| August 31, 2026 | 0.7673 |
| August 28, 2026 | 0.7633 |
| August 27, 2026 | 0.7786 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.12 |
| ACADIA Pharmaceuticals, Inc. | 2.756 |
| Alnylam Pharmaceuticals, Inc. | 5.852 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.534 |
Price to Book Value Related Metrics
| Price | 1.03 |
| Earnings Yield | -192.9% |
| Market Cap | 33.38M |